The validity of 5-aminorevrinic acid as a biomarker for risk screening and supportive diagnostic parameters in lung cancer patients.

Yoshikane Yamauchi,Yuichi Saito,Koji Murakami,Yasuyuki Kanamoto,Momoko Asami,Fumi Yokote,Takashi Sakai,Yukinori Sakao,Toru Tanaka,Masafumi Kawamura

The validity of 5-aminorevrinic acid as a biomarker for risk screening and supportive diagnostic parameters in lung cancer patients.

2020

Yoshikane Yamauchi
Yuichi Saito
Koji Murakami
Yasuyuki Kanamoto
Momoko Asami
Fumi Yokote
Takashi Sakai
Yukinori Sakao
Toru Tanaka
Masafumi Kawamura

e21027Background: Early detection and treatment of cancer is an important issue that affect the prognosis of cancer patients. Photodynamic screening with 5-aminorevrinic acid (ALA-PDS) is simple an...

Keywords:

Lung cancer
Oncology
Internal medicine
Biomarker (medicine)
risk screening
Pathology
Medicine
Cancer
early detection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations